This study evaluates the cost-effectiveness and budget impact to US payers of point-of-care nucleic acid amplification tests (NAAT) for group A streptococcus.
Mindy M. Cheng, PhD, MS
Advertisement
Articles by Mindy M. Cheng, PhD, MS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Emerging Data Suggest Survodutide Targets Liver Fat More Rapidly Than Weight Loss: Lee Kaplan, MD, PhD
2
Cicada COVID-19 Variant FAQs: Symptoms, Risk, and Prevention
3
Survodutide Normalizes Liver Fat in 61% of Patients With MASLD in Phase 3 Trial: Lee Kaplan, MD, PhD
4
Social Factors Shape Diabetes, Dementia Risk Across Populations
5